A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS Heparin Management in Cardiopulmonary Bypass Cardiac Surgical Patients

Gregory A. Nuttall, Mark M. Smith, Bradford B. Smith, Jon M. Christensen, Paula J. Santrach, Hartzell V. Schaff

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS Heparin Management in Cardiopulmonary Bypass Cardiac Surgical Patients'. Together they form a unique fingerprint.

Medicine & Life Sciences